Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$618M |
| 2 |
Vale
VALE
|
+$332M |
| 3 |
CELG
Celgene Corp
CELG
|
+$309M |
| 4 |
CME Group
CME
|
+$306M |
| 5 |
Amazon
AMZN
|
+$290M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$435M |
| 2 |
Meta Platforms (Facebook)
META
|
+$342M |
| 3 |
Crown Castle
CCI
|
+$244M |
| 4 |
SLB Ltd
SLB
|
+$229M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.17% |
| 2 | Technology | 14.41% |
| 3 | Consumer Discretionary | 10.61% |
| 4 | Financials | 10.51% |
| 5 | Real Estate | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2151
Heritage Insurance Holdings
HRTG
$989M
| $2.73M | ﹤0.01% |
186,800
+26,890
| +17% | +$397K |
|
2152
Lexicon Pharmaceuticals
LXRX
$1.04B
| $2.72M | ﹤0.01% |
489,513
+145,027
| +42% | +$881K |
|
|
IVAC
2153
DELISTED
Intevac Inc
IVAC
| $2.72M | ﹤0.01% |
444,008
+56,108
| +14% | +$323K |
|
2154
Stantec
STN
$8.44B
| $2.72M | ﹤0.01% |
114,900
+5,900
| +5% | +$140K |
|
2155
Genworth Financial
GNW
$3.77B
| $2.71M | ﹤0.01% |
709,000
+50,500
| +8% | +$221K |
|
|
HI
2156
DELISTED
Hillenbrand
HI
| $2.71M | ﹤0.01% |
65,310
-232,090
| -78% | -$9.8M |
|
|
GHL
2157
DELISTED
Greenhill & Co., Inc.
GHL
| $2.71M | ﹤0.01% |
125,900
+38,100
| +43% | +$946K |
|
2158
Ascent Industries
ACNT
$134M
| $2.71M | ﹤0.01% |
178,100
-16,800
| -9% | -$253K |
|
|
XRN
2159
Chiron Real Estate Inc
XRN
$484M
| $2.7M | ﹤0.01% |
54,989
+51,300
| +1,391% | +$2.53M |
|
|
LONE
2160
DELISTED
Lonestar Resources US Inc. Class A Common Stock
LONE
| $2.69M | ﹤0.01% |
671,300
-166,600
| -20% | -$778K |
|
2161
Larimar Therapeutics
LRMR
$444M
| $2.69M | ﹤0.01% |
81,715
+16,998
| +26% | +$871K |
|
2162
Celldex Therapeutics
CLDX
$3.35B
| $2.68M | ﹤0.01% |
545,106
+102,625
| +23% | +$540K |
|
2163
Navios Maritime Partners
NMM
$2.31B
| $2.68M | ﹤0.01% |
196,440
-39,127
| -17% | -$594K |
|
2164
Harvard Bioscience
HBIO
$30.4M
| $2.68M | ﹤0.01% |
62,150
-7,841
| -11% | -$284K |
|
2165
Liberty Latin America Class A
LILA
$1.67B
| $2.68M | ﹤0.01% |
+216,088
| New | +$2.52M |
|
|
ELVT
2166
DELISTED
Elevate Credit, Inc.
ELVT
| $2.65M | ﹤0.01% |
611,100
+68,700
| +13% | +$309K |
|
|
INSY
2167
DELISTED
Insys Therapeutics, Inc.
INSY
| $2.65M | ﹤0.01% |
+573,735
| New | +$2.72M |
|
2168
BK Technologies
BKTI
$286M
| $2.65M | ﹤0.01% |
124,660
+1,860
| +2% | +$38.9K |
|
|
VSI
2169
DELISTED
Vitamin Shoppe Inc.
VSI
| $2.64M | ﹤0.01% |
375,200
+281,000
| +298% | +$1.66M |
|
2170
KBR
KBR
$4.81B
| $2.63M | ﹤0.01% |
138,000
-469,000
| -77% | -$8.47M |
|
|
ENBL
2171
DELISTED
ENABLE MIDSTREAM PARTNERS, LP
ENBL
| $2.63M | ﹤0.01% |
183,900
+156,900
| +581% | +$2.34M |
|
2172
National Fuel Gas
NFG
$7.75B
| $2.63M | ﹤0.01% |
43,183
-50,400
| -54% | -$2.93M |
|
2173
Insteel Industries
IIIN
$634M
| $2.62M | ﹤0.01% |
125,141
+18,801
| +18% | +$414K |
|
|
SCHR
2174
Schwab Intermediately-Term US Treasury ETF
SCHR
$13.3B
| $2.61M | ﹤0.01% |
+97,142
| New | +$2.58M |
|
2175
POSCO
PKX
$17.1B
| $2.61M | ﹤0.01% |
47,300
+36,400
| +334% | +$2.11M |
|
Similar funds
Jim Simons's Q1 2019 Portfolio in Review
As of Q1 2019, Jim Simons held 3,883 positions worth $110B, up 20% from $91.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
Jim Simons deployed $7.09B of net new capital in Q1 2019, opening 532 new positions and adding to 1,751 existing holdings. Its largest new stake was Amazon: 3,483,100 shares worth $310M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $342M trimmed.
- Jim Simons's largest Q1 2019 buy was Amazon: 3,483,100 shares worth $310M.
- Jim Simons added most to Starbucks in Q1 2019, an estimated $618M increase.
- Jim Simons's biggest Q1 2019 reduction was Meta Platforms (Facebook), cutting an estimated $342M.
- Jim Simons fully exited Apple in Q1 2019, selling an estimated $435M.
- Jim Simons's ten largest holdings make up 8.7% of its $110B portfolio in Q1 2019.
- Jim Simons opened 532 new positions and closed 465 in Q1 2019.
- Jim Simons's portfolio value rose 20% quarter-over-quarter to $110B.
Based on Renaissance Technologies's 13F filing for Q1 2019, filed 14 May 2019.